San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Hims & Hers Health, Inc. sees 38% YoY subscriber growth, driven by 70% choosing personalized treatments. Click for my updated look at HIMS stock prospects.

In the current session, the stock is trading at $53.36, after a 1.12% spike. Over the past month, Hims & Hers Health Inc. HIMS stock increased by 8.11%, and in the past year, by 159.83%. With ...

Citi is holding firm on its Sell rating for Hims & Hers Health, Inc. (NYSE: HIMS), according to a report released on June 3, keeping a $30 price target even as the company moves to expand its ...

The move will rapidly expand Hims & Hers’ reach, which has a current base of 2.4 million U.S. customers. As the only digital health company with over a decade of operations across Germany ...

Its price-to-earnings ratio stands at 72.1, nearly three times higher than the market’s 26.4. Even when evaluating free cash flow, HIMS demands 35.5 times its cash generation, compared to 20.5 ...

Hims & Hers Health, Inc. HIMS announced that eligible customers can now access six months of prescription-only Wegovy at a new, affordable price. The company, via this offer, aims to make proven ...

Hims & Hers Health, Inc. (NYSE: HIMS) today announced eligible customers can access 6 months of prescription-only Wegovy® at a new, affordable price, making ...